Evaluation of the ability of Bifidobacterium longum to metabolize human intestinal mucus

FEMS Microbiology Letters

Volumn 314, Issue 2, 2011, Pages 125-130

  Ruiz, Lorena ^a   Gueimonde, Miguel ^a,b   Couté, Yohann ^c   Salminen, Seppo ^b   Sanchez, Jean Charles ^c   De Los Reyes Gavilán, Clara G ^a   Margolles, Abelardo ^a  

^a DEPARTMENT OF MICROBIOLOGY AND BIOCHEMISTRY OF DAIRY PRODUCTS   (Spain)

^b UNIVERSITY OF TURKU   (Finland)

^c UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Bifidobacterium longum; Human intestinal mucus; Proteome

Indexed keywords

ALPHA ARABINOFURANOSIDASE; ALPHA DEXTRO GALACTOPYRANOSIDASE; BACTERIAL ENZYME; BETA DEXTRO GALACTOPYRANOSIDASE; BETA DEXTRO XYLOPYRANOSIDASE; CYTOPLASM PROTEIN; ELONGATION FACTOR TS; GLYCOSIDASE; ISOMERASE; KETOL ACID REDUCTOISOMERASE; KETOL ACID REDUCTOISOMERASE 1; LEUCINE; MUCIN; N ACETYL BETA GLUCOSAMINIDASE; PROTEOME; RIBOSE 5 PHOSPHATE; UNCLASSIFIED DRUG;

BACTERIAL GROWTH; BACTERIAL METABOLISM; BACTERIAL STRAIN; BACTERIUM CULTURE; BIFIDOBACTERIUM LONGUM; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ECOLOGICAL NICHE; ENERGY RESOURCE; ENZYME ACTIVITY; FUNCTIONAL PROTEOMICS; GLUCOSE INTAKE; HUMAN; HUMAN TISSUE; INTESTINE FLORA; INTESTINE MUCOSA; ISOTOPE LABELING; LETTER; MUCUS; NONHUMAN; ORGANISMAL INTERACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN HYDROLYSIS; TISSUE METABOLISM;

AMINO ACIDS; BACTERIAL PROTEINS; BIFIDOBACTERIUM; CULTURE MEDIA; CYTOPLASM; GLYCOPROTEINS; GLYCOSIDE HYDROLASES; HUMANS; ISOTOPES; MUCUS; PROTEOME; STAINING AND LABELING;

BACTERIA (MICROORGANISMS); BIFIDOBACTERIUM LONGUM;

EID: 78650188880     PISSN: 03781097     EISSN: 15746968     Source Type: Journal    
DOI: 10.1111/j.1574-6968.2010.02159.x     Document Type: Letter

References (26)

1. Couté Y, Hernandez C, Appel RD, Sanchez JC & Margolles A (2007) Labeling of Bifidobacterium longum cells with 13C-substituted leucine for quantitative proteomic analyses. Appl Environ Microb 73: 5653-5656.
2. Derrien M, Vaughan EE, Plugge CM & de Vos WM (2004) Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium. Int J Syst Evol Micr 54: 1469-1476.
3. Granato D, Bergonzelli GE, Pridmore RD, Marvin L, Rouvet M & Corthésy-Theulaz IE (2004) Cell surface-associated elongation factor Tu mediates the attachment of Lactobacillus johnsonii NCC533 (La1) to human intestinal cells and mucins. Infect Immun 72: 2160-2169.
4. Gueimonde M, Ouwehand A, Huhtinen H, Salminen E & Salminen S (2007) Qualitative and quantitative analyses of the bifidobacterial microbiota in the colonic mucosa of patients with colorectal cancer, diverticulitis and inflammatory bowel disease. World J Gastroentero 13: 3985-3989.
5. Hamer HM, Jonkers DM, Loof A et al. (2009) Analyses of human colonic mucus obtained by an in vivo sampling technique. Dig Liver Dis 41: 559-564.
6. Harmsen HJ, Wildeboer-Veloo AC, Raangs GC, Wagendorp AA, Klijn N, Bindels JG & Welling GW (2000) Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods. J Pediatr Gastr Nutr 30: 61-67.
7. Homer KA, Whiley RA & Beighton D (1994) Production of specific glycosidase activities by Streptococcus intermedius strain UNS35 grown in the presence of mucin. J Med Microbiol 41: 184-190.
8. Karamanos Y, Bourgerie S, Barreaud JP & Julien R (1995) Are there biological functions for bacterial endo-N-acetyl-beta-d-glucosaminidases? Res Microbiol 146: 437-443.
9. Katayama T, Sakuma A, Kimura T, Makimura Y, Hiratake J, Sakata K, Yamanoi T, Kumagai H & Yamamoto K (2004) Molecular cloning and characterization of Bifidobacterium bifidum 1, 2-alpha-l-fucosidase (AfcA), a novel inverting glycosidase (glycoside hydrolase family 95). J Bacteriol 186: 4885-4893.
10. Katayama T, Fujita K & Yamamoto K (2005) Novel bifidobacterial glycosidases acting on sugar chains of mucin glycoproteins. J Biosci Bioeng 99: 457-465.
11. Lay C, Rigottier-Gois L, Holmstrøm K et al. (2005) Colonic microbiota signatures across five northern European countries. Appl Environ Microb 71: 4153-4155.
12. Leitch EC, Walker AW, Duncan SH, Holtrop G & Flint HJ (2007) Selective colonization of insoluble substrates by human faecal bacteria. Environ Microbiol 9: 667-679.
13. Macfarlane S, Woodmansey EJ & Macfarlane GT (2005) Colonization of mucin by human intestinal bacteria and establishment of biofilm communities in a two-stage continuous culture system. Appl Environ Microb 71: 7483-7492.
14. Masco L, Huys G, De Brandt E, Temmerman R & Swings J (2005) Culture-dependent and culture-independent qualitative analysis of probiotic products claimed to contain bifidobacteria. Int J Food Microbiol 102: 221-230.
15. O'Riordan K & Fitzgerald GF (1998) Evaluation of bifidobacteria for the production of antimicrobial compounds and assessment of performance in cottage cheese at refrigeration temperature. J Appl Microbiol 85: 103-114.
16. Ouwehand AC, Salminen S, Tölkkö S, Roberts P, Ovaska J & Salminen E (2002) Resected human colonic tissue: new model for characterizing adhesion of lactic acid bacteria. Clin Diagn Lab Immun 9: 184-186.
17. Ruas-Madiedo P, Hernández-Barranco A, Margolles A & de los Reyes-Gavilán CG (2005) A bile salt-resistant derivative of Bifidobacterium animalis has an altered fermentation pattern when grown on glucose and maltose. Appl Environ Microb 71: 6564-6570.
18. Ruas-Madiedo P, Gueimonde M, Fernández-García M, de los Reyes-Gavilán CG & Margolles A (2008) Mucin degradation by Bifidobacterium strains isolated from the human intestinal microbiota. Appl Environ Microb 74: 1936-1940.
19. Ruiz L, Couté Y, Sánchez B, de los Reyes-Gavilán CG, Sanchez JC & Margolles A (2009a) The cell-envelope proteome of Bifidobacterium longum in an in vitro bile environment. Microbiology-SGM 155: 957-967.
20. Ruiz L, Sánchez B, de Los Reyes-Gavilán CG, Gueimonde M & Margolles A (2009b) Coculture of Bifidobacterium longum and Bifidobacterium breve alters their protein expression profiles and enzymatic activities. Int J Food Microbiol 133: 148-153.
21. Salminen SJ, Gueimonde M & Isolauri E (2005) Probiotics that modify disease risk. J Nutr 135: 1294-1298.
22. Sánchez B, Ruiz L, de los Reyes-Gavilán CG & Margolles A (2008) Proteomics of stress response in Bifidobacterium. Front Biosci 13: 6905-6919.
23. Tu QV, McGuckin MA & Mendz GL (2008) Campylobacter jejuni response to human mucin MUC2: modulation of colonization and pathogenicity determinants. J Med Microbiol 57: 795-802.
24. Turroni F, Foroni E, Pizzetti P et al. (2009a) Exploring the diversity of the bifidobacterial population in the human intestinal tract. Appl Environ Microb 75: 1534-1545.
25. Turroni F, Marchesi JR, Foroni E, Gueimonde M, Shanahan F, Margolles A, van Sinderen D & Ventura M (2009b) Microbiomic analysis of the bifidobacterial population in the human distal gut. ISME J 3: 745-751.
26. Wu Z, Zhang W & Lu C (2008) Immunoproteomic assay of surface proteins of Streptococcus suis serotype 9. FEMS Immunol Med Mic 53: 52-59.